Eptifibatide (Amneal Biosciences)
Welcome to the PulseAid listing for the Eptifibatide drug offered from Amneal Biosciences. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Amneal Biosciences |
| NON-PROPRIETARY NAME: | Eptifibatide |
| SUBSTANCE NAME: | EPTIFIBATIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-12-08 |
| END MARKETING DATE: | 0000-00-00 |
Eptifibatide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Eptifibatide from Amneal Biosciences |
| LABELER NAME: | Amneal Biosciences |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/mL) |
| START MARKETING DATE: | 2016-12-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70121-1002_8870ef60-feaa-4a33-84e6-1b630b1ecbdf |
| PRODUCT NDC: | 70121-1002 |
| APPLICATION NUMBER: | ANDA205581 |
Other EPTIFIBATIDE Pharmaceutical Manufacturers / Labelers:
